Page 8 - Peter Hecht News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ariadne Labs Names Two New Members to Advisory Board News provided by Share this article Share this article BOSTON, Jan. 12, 2021 /PRNewswire/ -- Today, Ariadne Labs welcomes two new members to its Advisory Board. Elliot Cohen and Karin Leschly will be joining the Advisory Board as trusted advisors and dedicated ambassadors to Ariadne Labs' mission to create scalable solutions that improve health care delivery at the most critical moments for people everywhere. Ariadne Labs welcomes Elliot Cohen and Karin Leschly to its Advisory Board. "We are excited to welcome Elliot and Karin to the Advis...

Cheryl Gault promoted to Chief Operating Officer Amy Schulman stepping down from Board of Directors CAMBRIDGE, Mass., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company developing innovative medicines for people with serious diseases of the central nervous system (CNS), today announced, effective January 1, 2021, the promotions of Cheryl Gault to Chief Operating Officer and Anjeza Gjino to Chief Financial Officer. Bill Huyett, the Company’s current CFO, will continue to work part-time as a Strategic Advisor providing s...

Alexion sale will go down as one of the biggest buyouts in Boston history Local leaders look on the bright side: AstraZeneca’s decision to base its rare-disease business here By Jon Chesto Globe Staff,Updated December 14, 2020, 7:54 p.m. Email to a Friend Reflections are seen on a sign outside the global headquarters of AstraZeneca in London. England-based pharmaceutical company AstraZeneca, which is involved in development of a COVID-19 vaccine, said during the weekend it is acquiring Boston-based drug developer Alexion Pharmaceuticals in a deal worth $39 billion.Kirsty Wigglesworth/Ass...